MiRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer

Biochemical and Biophysical Research Communications

Volumn 398, Issue 1, 2010, Pages 1-6

  Guo, Xiaobo ^a,b   Guo, Lei ^a   Ji, Jun ^a   Zhang, Jianian ^a   Zhang, Jun ^a   Chen, Xuehua ^a   Cai, Qu ^a   Li, Jianfang ^a   Gu, Qinlong ^a   Liu, Bingya ^a   Zhu, Zhenggang ^a   Yu, Yingyan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

E2F1; Gastric cancer; Growth arrest; MiR 331 3p

Indexed keywords

MICRORNA; MIRNA 331 3P; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; STOMACH CANCER;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; STOMACH NEOPLASMS;

EID: 77954757263     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.05.082     Document Type: Article

References (33)

1. Forman D., Burley V.J. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract. Res. Clin. Gastroenterol. 2006, 20:633-649.
2. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. N Engl. J. Med. 2001, 345:784-789.
3. Yang L. Incidence and mortality of gastric cancer in China. World J. Gastroenterol. 2006, 12:17-20.
4. Becker K.F., Keller G., Hoefler H. The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg. Oncol. 2000, 9:5-11.
5. Petrocca F., Visone R., Onelli M.R., Shah M.H., Nicoloso M.S., de Martino I., Iliopoulos D., Pilozzi E., Liu C.G., Negrini M., Cavazzini L., Volinia S., Alder H., Ruco L.P., Baldassarre G., Croce C.M., Vecchione A. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13:272-286.
6. Gorgoulis V.G., Zacharatos P., Mariatos G., Kotsinas A., Bouda M., Kletsas D., Asimacopoulos P.J., Agnantis N., Kittas C., Papavassiliou A.G. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J. Pathol. 2002, 198:142-156.
7. Eymin B., Gazzeri S., Brambilla C., Brambilla E. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene 2001, 20:1678-1687.
8. Yang X.H., Sladek T.L. Overexpression of the E2F-1 transcription factor gene mediates cell transformation. Gene Expr. 1995, 4:195-204.
9. Suh D.S., Yoon M.S., Choi K.U., Kim J.Y. Significance of E2F-1 overexpression in epithelial ovarian cancer. Int. J. Gynecol. Cancer 2008, 18:492-498.
10. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
11. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
12. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
13. Zhang H., Li Y., Lai M. The microRNA network and tumor metastasis. Oncogene 2010, 29:937-948.
14. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 2007, 6:60.
15. Krutzfeldt J., Poy M.N., Stoffel M. Strategies to determine the biological function of microRNAs. Nat. Genet. 2006, 38(Suppl.):S14-S19.
16. Epis M.R., Giles K.M., Barker A., Kendrick T.S., Leedman P.J. miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. J. Biol. Chem. 2009, 284:24696-24704.
17. Wang L., Oberg A.L., Asmann Y.W., Sicotte H., McDonnell S.K., Riska S.M., Liu W., Steer C.J., Subramanian S., Cunningham J.M., Cerhan J.R., Thibodeau S.N. Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines. PLoS One 2009, 4:e5878.
18. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., Banham A.H., Pezzella F., Boultwood J., Wainscoat J.S., Hatton C.S., Harris A.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141:672-675.
19. Lu Z., Liu M., Stribinskis V., Klinge C.M., Ramos K.S., Colburn N.H., Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008, 27:4373-4379.
20. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
21. Guo J., Miao Y., Xiao B., Huan R., Jiang Z., Meng D., Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol. 2009, 24:652-657.
22. Katada T., Ishiguro H., Kuwabara Y., Kimura M., Mitui A., Mori Y., Ogawa R., Harata K., Fujii Y. MicroRNA expression profile in undifferentiated gastric cancer. Int. J. Oncol. 2009, 34:537-542.
23. Kim Y.K., Yu J., Han T.S., Park S.Y., Namkoong B., Kim D.H., Hur K., Yoo M.W., Lee H.J., Yang H.K., Kim V.N. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009, 37:1672-1681.
24. Liu T., Tang H., Lang Y., Liu M., Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibition. Cancer Lett. 2009, 273:233-242.
25. Motoyama K., Inoue H., Nakamura Y., Uetake H., Sugihara K., Mori M. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin. Cancer Res. 2008, 14:2334-2340.
26. Y. Zhang, J. Guo, D. Li, B. Xiao, Y. Miao, Z. Jiang, H. Zhuo, Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance, Med. Oncol. (2009), July 14. [Epub ahead of print].
27. Zhang Z., Li Z., Gao C., Chen P., Chen J., Liu W., Xiao S., Lu H. MiR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab. Invest. 2008, 88:1358-1366.
28. Saito Y., Friedman J.M., Chihara Y., Egger G., Chuang J.C., Liang G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem. Biophys. Res. Commun. 2009, 379:726-731.
29. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
30. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
31. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
32. Johnson C.D., Esquela-Kerscher A., Stefani G., Byrom M., Kelnar K., Ovcharenko D., Wilson M., Wang X., Shelton J., Shingara J., Chin L., Brown D., Slack F.J. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 2007, 67:7713-7722.
33. Zhang B., Pan X., Cobb G.P., Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302:1-12.